Tim Evans
Stock Analyst at Wells Fargo
(2.38)
# 2,572
Out of 5,065 analysts
23
Total ratings
72.73%
Success rate
4.35%
Average return
Main Sectors:
Stocks Rated by Tim Evans
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIO Bio-Rad Laboratories | Maintains: Outperform | $290 → $280 | $316.70 | -11.59% | 2 | Feb 28, 2018 | |
| BIO.B Bio-Rad Laboratories | Maintains: Outperform | $290 → $280 | $318.52 | -12.09% | 2 | Feb 28, 2018 | |
| MEDP Medpace Holdings | Maintains: Market Perform | $38 → $35 | $591.82 | -94.09% | 3 | Feb 28, 2018 | |
| ILMN Illumina | Upgrades: Outperform | n/a | $123.85 | - | 2 | Jan 2, 2018 | |
| WST West Pharmaceutical Services | Maintains: Outperform | $105 → $112 | $271.07 | -58.68% | 4 | Oct 27, 2017 | |
| DGX Quest Diagnostics | Maintains: Market Perform | $88 → $86 | $191.25 | -55.03% | 2 | Oct 20, 2017 | |
| LH Labcorp Holdings | Reinstates: Outperform | $175 | $265.64 | -34.12% | 1 | Oct 12, 2017 | |
| TECH Bio-Techne | Initiates: Market Perform | n/a | $61.53 | - | 1 | Jul 13, 2017 | |
| DHR Danaher | Initiates: Market Perform | $90 | $227.39 | -60.42% | 1 | Jul 13, 2017 | |
| MTD Mettler-Toledo International | Upgrades: Outperform | n/a | $1,452.35 | - | 1 | Jul 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $47.27 | - | 2 | Jul 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $151.25 | - | 1 | Jul 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $1.31 | - | 1 | May 3, 2017 |
Bio-Rad Laboratories
Feb 28, 2018
Maintains: Outperform
Price Target: $290 → $280
Current: $316.70
Upside: -11.59%
Bio-Rad Laboratories
Feb 28, 2018
Maintains: Outperform
Price Target: $290 → $280
Current: $318.52
Upside: -12.09%
Medpace Holdings
Feb 28, 2018
Maintains: Market Perform
Price Target: $38 → $35
Current: $591.82
Upside: -94.09%
Illumina
Jan 2, 2018
Upgrades: Outperform
Price Target: n/a
Current: $123.85
Upside: -
West Pharmaceutical Services
Oct 27, 2017
Maintains: Outperform
Price Target: $105 → $112
Current: $271.07
Upside: -58.68%
Quest Diagnostics
Oct 20, 2017
Maintains: Market Perform
Price Target: $88 → $86
Current: $191.25
Upside: -55.03%
Labcorp Holdings
Oct 12, 2017
Reinstates: Outperform
Price Target: $175
Current: $265.64
Upside: -34.12%
Bio-Techne
Jul 13, 2017
Initiates: Market Perform
Price Target: n/a
Current: $61.53
Upside: -
Danaher
Jul 13, 2017
Initiates: Market Perform
Price Target: $90
Current: $227.39
Upside: -60.42%
Mettler-Toledo International
Jul 13, 2017
Upgrades: Outperform
Price Target: n/a
Current: $1,452.35
Upside: -
Jul 13, 2017
Downgrades: Underperform
Price Target: n/a
Current: $47.27
Upside: -
Jul 13, 2017
Upgrades: Outperform
Price Target: n/a
Current: $151.25
Upside: -
May 3, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $1.31
Upside: -